本页面由Tiger Trade Technology Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

38.45
-0.6100-1.56%
盘前:38.33-0.1200-0.31%04:01 EDT
成交量:153.67万
成交额:5,948.75万
市值:41.76亿
市盈率:-20.78
高:39.36
开:39.12
低:38.32
收:39.06
52周最高:48.51
52周最低:14.25
股本:1.09亿
流通股本:8,817.09万
量比:1.08
换手率:1.74%
股息:- -
股息率:- -
每股收益(TTM):-1.8502
每股收益(LYR):-1.6302
净资产收益率:-38.03%
总资产收益率:-25.03%
市净率:9.32
市盈率(LYR):-23.59

数据加载中...

2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report
2021/03/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/05

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933